H. J. Xu

发表

Elevated and absent pRb expression is associated with bladder cancer progression and has cooperative effects with p53.

S. Groshen, R. Cote, W. Benedict, 1998, Cancer research.

Absence of retinoblastoma protein expression in primary non-small cell lung carcinomas.

G E Moore, G. Moore, W. Benedict, 1991, Cancer research.

Strategies for approaching retinoblastoma tumor suppressor gene therapy.

H. J. Xu, H. J. Xu, H. J. Xu, 1997, Advances in pharmacology.

Loss of heterozygosity occurs centromeric to RB without associated abnormalities in the retinoblastoma gene in tumors from patients with metastatic renal cell carcinoma.

J. Gnarra, C. Florence, M. Walther, 1995, The Journal of urology.

Inactivation of the retinoblastoma gene in human bladder and renal cell carcinomas.

S. Maeda, W. Benedict, R. Takahashi, 1991, Cancer research.

Characterization of intragenic deletions in two sporadic germinal mutation cases of retinoblastoma resulting in abnormal gene expression.

W. Benedict, R. Takahashi, D. Yandell, 1991, Oncogene.

Loss of heterozygosity on chromosome 13 is common only in the biologically more aggressive subtypes of ovarian epithelial tumors and is associated with normal retinoblastoma gene expression.

W. Benedict, L. Dubeau, H. J. Xu, 1994, Cancer research.

Evidence of functional RB protein in epithelial ovarian carcinomas despite loss of heterozygosity at the RB locus.

W. Benedict, W. Cliby, J. Li, 1994, Cancer research.

Growth-factor stimulation reveals two mechanisms of retinoblastoma gene inactivation in human myelogenous leukemia cells.

M. Andreeff, W. Benedict, S. Kornblau, 1995, Leukemia & lymphoma.

Levels of retinoblastoma protein expression in newly diagnosed acute myelogenous leukemia.

E. Estey, W. Benedict, S. Kornblau, 1994, Blood.

Clinical implications of decreased retinoblastoma protein expression in acute myelogenous leukemia.

E. Estey, M. Andreeff, S. Kornblau, 1992, Cancer research.

Low and maximally phosphorylated levels of the retinoblastoma protein confer poor prognosis in newly diagnosed acute myelogenous leukemia: a prospective study.

E. Estey, M. Andreeff, W. Benedict, 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

Lack of nuclear RB protein staining in G0/middle G1 cells: correlation to changes in total RB protein level.

W. Benedict, H. J. Xu, S. Hu, 1991, Oncogene.

Altered retinoblastoma protein expression and prognosis in early-stage non-small-cell lung carcinoma.

W. Benedict, D. Quinlan, A. Davidson, 1994, Journal of the National Cancer Institute.

Role of the retinoblastoma gene in the initiation and progression of human cancer.

W. Benedict, R. Takahashi, S. Hu, 1990, The Journal of clinical investigation.

The retinoblastoma gene functions as a growth and tumor suppressor in human bladder carcinoma cells.

W. Benedict, S. Aaronson, R. Takahashi, 1991, Proceedings of the National Academy of Sciences of the United States of America.

Altered expression of retinoblastoma protein and known prognostic variables in locally advanced bladder cancer.

A. Sahin, C. Logothetis, W. Benedict, 1992, Journal of the National Cancer Institute.

Intraocular tumor formation of RB reconstituted retinoblastoma cells.

G. Klein, W. Benedict, J. Sumegi, 1991, Cancer research.

Enhanced tumor cell growth suppression by an N-terminal truncated retinoblastoma protein.

W. Benedict, J. Li, H. J. Xu, 1994, Proceedings of the National Academy of Sciences of the United States of America.

The retinoblastoma susceptibility gene product: a characteristic pattern in normal cells and abnormal expression in malignant cells.

W. Benedict, R. Takahashi, H. J. Xu, 1989, Oncogene.

Deletions of chromosome 13q, mutations in Retinoblastoma 1, and retinoblastoma protein state in human hepatocellular carcinoma.

S. Hirohashi, W. Benedict, T. Sekiya, 1994, Cancer research.

Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.

A. Thor, W. Benedict, V. Cryns, 1994, The New England journal of medicine.

Cooperative effects of p53 and pRB alterations in primary superficial bladder tumors.

C. Cordon-Cardo, V. Reuter, W. Benedict, 1997, Cancer research.

Enhanced tumor suppressor gene therapy via replication-deficient adenovirus vectors expressing an N-terminal truncated retinoblastoma protein.

W. Benedict, J. Seigne, J. Li, 1996, Cancer research.

Infrequent inactivation of the retinoblastoma gene despite frequent loss of chromosome 13q in head and neck squamous cell carcinoma.

R. Hruban, D. Sidransky, W. Benedict, 1994, Cancer research.

Altered retinoblastoma and p53 protein status in non-small cell carcinoma of the lung: potential synergistic effects on prognosis.

W. Benedict, P. Cagle, J. Li, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Genetic disparity between morphologically benign cysts contiguous to ovarian carcinomas and solitary cystadenomas.

W. Benedict, L. Dubeau, H. J. Xu, 1995, Journal of the National Cancer Institute.

Apoptosis-independent retinoblastoma protein rescue of HLA class II messenger RNA IFN-gamma inducibility in non-small cell lung carcinoma cells. Lack of surface class II expression associated with a specific defect in HLA-DRA induction.

J. Boss, H. J. Xu, S. Hu, 1996, Journal of immunology.

Development of an adenovirus vector with tetracycline-regulatable human tumor necrosis factor alpha gene expression.

C. Logothetis, W. Ji, Y. Zhou, 1997, Cancer research.

The loss of retinoblastoma gene in association with c-myc and transforming growth factor-beta 1 gene expression in human bladder cancer.

W. Benedict, T. Shuin, S. Noguchi, 1995, The Journal of urology.